Source fact
us-gaap:Revenues
0001156375-26-000047
Financials · CME
CME Group
Reported results, filing history, and direct access to the source documents.
LATEST QUARTERLY REPORT
10-Q · Period ended 2026-06-30
Filed 2026-07-24. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:NetIncomeLoss
0001156375-26-000047
Source fact
us-gaap:Assets
0001156375-26-000047
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0001156375-26-000047
LATEST ANNUAL REPORT
10-K · Period ended 2025-12-31
Filed 2026-02-26. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:Revenues
0001156375-26-000009
Source fact
us-gaap:NetIncomeLoss
0001156375-26-000009
Source fact
us-gaap:Assets
0001156375-26-000009
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0001156375-26-000009
Disclosure timeline
Latest tracked 10-K, 10-Q, amendments, and earnings-related 8-K Item 2.02 filings. Amendments are listed but do not automatically replace the original report's facts.
10-Q · Period ended 2026-06-30 →Accession 0001156375-26-000047
8-K · Results of operations disclosure →Accession 0001156375-26-000042
10-Q · Period ended 2026-03-31 →Accession 0001156375-26-000020
8-K · Results of operations disclosure →Accession 0001156375-26-000016
10-K · Period ended 2025-12-31 →Accession 0001156375-26-000009
8-K · Results of operations disclosure →Accession 0001156375-26-000006
10-Q · Period ended 2025-09-30 →Accession 0001156375-25-000206
8-K · Results of operations disclosure →Accession 0001156375-25-000204
10-Q · Period ended 2025-06-30 →Accession 0001156375-25-000182
8-K · Results of operations disclosure →Accession 0001156375-25-000176
10-Q · Period ended 2025-03-31 →Accession 0001156375-25-000103
8-K · Results of operations disclosure →Accession 0001156375-25-000093
10-K · Period ended 2024-12-31 →Accession 0001156375-25-000021
8-K · Results of operations disclosure →Accession 0001156375-25-000007
10-Q · Period ended 2024-09-30 →Accession 0001156375-24-000200
8-K · Results of operations disclosure →Accession 0001156375-24-000187
10-Q · Period ended 2024-06-30 →Accession 0001156375-24-000149
8-K · Results of operations disclosure →Accession 0001156375-24-000143
10-Q · Period ended 2024-03-31 →Accession 0001156375-24-000072
8-K · Results of operations disclosure →Accession 0001156375-24-000070
10-K · Period ended 2023-12-31 →Accession 0001156375-24-000010
8-K · Results of operations disclosure →Accession 0001156375-24-000007
10-Q · Period ended 2023-09-30 →Accession 0001156375-23-000190
8-K · Results of operations disclosure →Accession 0001156375-23-000174
Read with context.
These are automatically extracted filing facts, not a complete financial review. Different companies and report types may use different reporting periods and accounting definitions. Missing values are not zero. No stock prices, earnings forecasts, or buy/sell ratings are provided.
All SEC filings for this company · Sources, coverage, and methodology
For education and research only. Not investment advice. Verify original filings before making decisions.